In relation to the ATL1103 program, page-24

From The Prospectus on termination

Either party may terminate the License Agreement upon the occurrence of certain events, provided notice is given to the other party. We may terminate the License Agreement upon 90 days' prior written notice to Antisense Therapeutics

if we believe the further development and commercialization of COR-004 is no longer feasible due to a material change that is beyond our control.

If, however,

we terminate the License Agreement for convenience upon 90 days' prior written notice to Antisense Therapeutics prior to the filing of an NDA in the United States for COR-004, we must pay Antisense Therapeutics a $2.0 million termination fee.

So it looks like we will get FK all for termination of contract

Oh and by the way have you ever tried suing a piece of paper listed in the Caymen

BOY HAVE WE BEEN BENT OVER

AGAIN

The last balls up set us back 4yrs

I wonder how far will this put us back ask yourself will COR 5 now get to market infront of 1103

Tevas other drug for MS is now knocking on the door for approval and where are we with 1102

Fkn shambles, would be nice to see Issis throw a little support our way because by fk we are going to need it